The shareholders of Siegfried Holding AG approved all proposals put forward by the Board of Directors. They approved the increase of the distribution to the shareholders in the form of a repayment of the nominal value of the shares from 2.60 to 2.80 francs per registered share. Isabelle Welton was appointed to the Board of Directors of Siegfried Holding AG. The shareholders approved the remuneration of the Board of Directors and the Executive Committee.
The company’s 117th Annual Shareholders’ Meeting was held without physical attendance of shareholders in accordance with the Swiss Federal Council’s Covid-19 Ordinance. Voting was possible only via the independent voting proxy ahead of the Meeting. The event was transmitted on the internet per livestream. The Shareholders’ Meeting passed the following resolutions:
Peter Gehler, Chief Communications Officer
Tel. +41 62 746 11 48
Mob. +41 79 416 41 16
Siegfried Holding AG
Untere Bruehlstrasse 4
Tel. +41 62 746 11 11
The Siegfried Group is a global life sciences company with sites in Switzerland, the USA, Malta, China, Germany and France. In 2019, the company achieved sales of 833.5 million Swiss francs and currently employs about 2500 people at nine sites on three continents. Siegfried Holding AG is publicly listed on SIX Swiss Exchange (SIX: SFZN).
Siegfried is active in manufacturing pharmaceutical APIs (and their intermediates) as well as drug products (tablets, capsules, sterile vials, ampoules, and cartridges) for the pharmaceutical industry and provides development services.